International Journal of Infectious Diseases (Aug 2023)

First genome-wide association study for lymphatic filariasis in a West African population points to a human leukocyte antigen-mediated disease pathophysiology

  • Sandeep Grover,
  • Vera S. Opoku,
  • Linda B. Debrah,
  • Carlo Maj,
  • Jubin Osei-Mensah,
  • Derrick A. Mensah,
  • Achim Hoerauf,
  • Alexander Y. Debrah,
  • Johannes Schumacher,
  • Kenneth Pfarr

Journal volume & issue
Vol. 133
pp. 1 – 4

Abstract

Read online

Objectives: Lymphatic filariasis (LF) represents a parasitic disease caused by filarial nematodes. Although some infected individuals present an asymptomatic course, others suffer severe chronic lymphatic pathology, including lymphedema, hydrocele, and elephantiasis. Several studies have shown that host genetic factors influence LF susceptibility and chronic pathology. The current study aimed to conduct the first genome-wide association study to systematically determine LF susceptibility. Methods: We analyzed genome-wide single-nucleotide polymorphism data from 1459 LF cases and 1492 asymptomatic controls of West African (Ghanaian) descent. Results: We identified two independent genome-wide significant associated genetic variants near the genes HLA-DQB2 (rs7742085) and HLA-DQA1 (rs4959107) contributing to LF and/or lymphedema susceptibility (P 1.30). We also observed suggestive evidence of LF associations (P <1.0 × 10−6) at two non-HLA loci, near the genes ZFHX4-AS1 (rs79562145) and CHP2 (rs12933387). In contrast, we could not replicate any previously reported LF associations drawn from candidate gene association studies. On the polygenic level, we show that our genome-wide association study data explain 24-42% of LF heritability, depending on an assumed population prevalence of 0.5-5.0%. Conclusion: Our findings point to an involvement of HLA-mediated immune mechanisms in LF pathophysiology.

Keywords